Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Nader Al Nakouzi(University of British Columbia), Martin Gleave(University of British Columbia)
Cited by 31
Related Papers
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
|Cancer Discovery|2018|520
Antisense therapy for cancer
|Nature reviews. Cancer|2005|399
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
|JAMA Oncology|2016|384
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors
|Journal of Clinical Oncology|2007|219
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
|European Urology|2017|218